MENU
BOLT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Bolt Biotherapeutics (BOLT) Earnings Date & Reports
Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer... Show more
A.I. Advisor
published Earnings
BOLT is expected to report earnings to fall 47.48% to -240 cents per share on November 11
Q3'26
Est.
$-2.40
Q2'26
Missed
by $1.24
Q1'26
Missed
by $3.95
Q4'25
Missed
by $3.54
Q3'25
Missed
by $3.42
The last earnings report on August 11 showed earnings per share of -457 cents, missing the estimate of -332 cents. With 9.26K shares outstanding, the current market capitalization sits at 7.86M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
900 Chesapeake Drive
Phone
+1 650 665-9295
Employees
23
Web
https://www.boltbio.com